Dr. Reddy's recalls some lots of heartburn drug in U.S

MUMBAI Thu Mar 13, 2014 2:37pm IST

A pharmacy employee looks for medication as she works to fill a prescription while working at a pharmacy in New York December 23, 2009. REUTERS/Lucas Jackson/Files

A pharmacy employee looks for medication as she works to fill a prescription while working at a pharmacy in New York December 23, 2009.

Credit: Reuters/Lucas Jackson/Files

Related Topics

Stocks

   

MUMBAI (Reuters) - Generic drugmaker Dr. Reddy's Laboratories Ltd (REDY.NS) is recalling about 58,656 bottles of the heartburn drug lansoprazole in the United States due to a microbial contamination, the U.S. Food and Drug Administration said.

It was classified as a "Class II" recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.

While product recalls are not uncommon, the FDA announcement comes amid a string of quality problems for Indian drug makers.

In a weekly report, the U.S. regulator also announced it was banning imports from Sun Pharmaceutical Industries (SUN.NS) Karkhadi manufacturing plant in Gujarat.

And just last week, the FDA disclosed that products made by Sun Pharma and Ranbaxy Laboratories (RANB.NS) were being recalled.

Dr. Reddy's voluntary recall of lansoprazole delayed release capsules, a generic version of Swiss drugmaker Novartis' (NOVN.VX) drug Prevacid 24 HR, began on January 3, 2014, the FDA said on its website.

A spokesman for Dr. Reddy's was not immediately available to comment.

(Reporting by Zeba Siddiqui; Editing by Edwina Gibbs)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

COAL BLOCK ALLOCATIONS

REUTERS SHOWCASE

Banned From Bidding

Banned From Bidding

India bans Finmeccanica from bidding for contracts amid graft case.  Full Article 

Sugar Talk

Sugar Talk

Sugar export rebound at risk from rising domestic prices.  Full Article 

GDP Preview

GDP Preview

Economy likely grew faster in June quarter: Reuters poll.  Full Article 

New Ordeal

New Ordeal

After disasters, stricken Malaysia Airlines staff brace for job cuts.  Full Article 

Deal Talk

Deal Talk

Kleiner to invest in messaging startup Snapchat at near-$10 bln valuation - report.  Full Article 

Expert Zone

Expert Zone

Column - Why inflation is so persistent.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage